Nano-X Imaging Ltd.

Listed Company
NNOXCIK 0001795251NasdaqAcceleratedX-Ray Apparatus & Tubes & Related Irradiation ApparatusL3ILFY ends Dec 31
Period
FY 2025
Revenue
$13.02M
Net Income
$-75.02M
Total Assets
$162.16M
Equity
$139.73M
Shares Out
69.59M
Op. Cash Flow
$-40.79M

Business

Nano-X Imaging Ltd. develops and commercializes a modular medical imaging ecosystem centered on a novel digital X-ray source and associated devices. Its principal products and services include the Nanox. ARC tomosynthesis hardware, the Nanox. CLOUD software platform, the Nanox. SOURCE emitter, Nanox. AI diagnostic algorithms, the Nanox. MARKETPLACE teleradiology marketplace, Nanox. CONNECT integrations, and related teleradiology services. The company operates through product, AI solutions, cloud/marketplace and teleradiology segments and via OEM licensing. It sells and distributes globally, focusing on the U.S. and EU through direct MSaaS deployments, CapEx sales, local distributors and strategic partnerships to hospitals, clinics, outpatient facilities and imaging centers.

Summary from filing dated 2025-04-09

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue$13.02M
Net income$-75.02M
Total assets$162.16M
Total liabilities$22.43M
Stockholders' equity$139.73M
Operating cash flow$-40.79M

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro